...
首页> 外文期刊>Journal of Leukocyte Biology: An Official Publication of the Reticuloendothelial Society >Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy
【24h】

Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy

机译:抗逆转录病毒疗法在血液单核细胞中循环的HIV-1的持续进化:停止治疗的患者单核细胞和CD4 + T细胞中HIV-1的遗传分析

获取原文

摘要

The role of blood monocytes in HIV-1 infection is a relatively new field of interest. What happens to HIV-1 in monocytes and their relationship to CD4+ T cells before, during, and after suppressive antiretroviral therapy (ART) is largely unstudied. Here, considering that diversity is a good indicator of continued replication over time, we evaluated the effect of ART on HIV-1 in blood monocytes and CD4+ T cells by examining the diversity of HIV-1 from 4 infected patients who underwent and stopped therapy. We determined diversity and compartmentalization of HIV-1 between blood monocytes and CD4+ T cells in each patient in relationship to their ART regimens. Our data indicate that the rate of HIV-1 diversity increase in monocytes during therapy was significantly higher than in CD4+ T cells (P0.05), suggesting that HIV-1 present in monocytes diversify more during therapy than in CD4+ T cells. Increased rates of HIV-1 compartmentalization between monocytes and CD4+ T cells while on therapy were also observed. These results suggest that ART inhibits HIV-1 replication in CD4+ T cells more than in blood monocytes and that better treatments to combat HIV-1 in monocytes/macrophages may be needed for a more complete suppression of HIV replication.
机译:血液单核细胞在HIV-1感染中的作用是一个相对较新的领域。抑制性抗逆转录病毒治疗(ART)之前,期间和之后,单核细胞中HIV-1的变化及其与CD4 + T细胞的关系尚不清楚。在这里,考虑到多样性是随时间推移持续复制的良好指标,我们通过检查4名接受和停止治疗的感染患者的HIV-1多样性,评估了ART对血液单核细胞和CD4 + T细胞中HIV-1的影响。我们确定了每位患者的血液单核细胞和CD4 + T细胞之间的HIV-1多样性和区隔程度与他们的ART疗法相关。我们的数据表明,治疗期间单核细胞中HIV-1多样性增加的速率显着高于CD4 + T细胞中(P <0.05),这表明治疗期间单核细胞中HIV-1的多样性比CD4 + T细胞中的更多。还观察到在治疗时单核细胞和CD4 + T细胞之间的HIV-1间隔增加。这些结果表明,ART比血液单核细胞更能抑制CD4 + T细胞中HIV-1的复制,为了更完全地抑制HIV复制,可能需要更好的治疗方法来对抗单核细胞/巨噬细胞中的HIV-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号